サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363170

医療機器償還の市場規模、シェア、動向分析レポート：支払者別、ヘルスケア環境別、地域別、セグメント別予測、2023年～2030年

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 275 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
医療機器償還の市場規模、シェア、動向分析レポート：支払者別、ヘルスケア環境別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月22日
発行: Grand View Research
ページ情報: 英文 275 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療機器償還市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医療機器償還市場規模は、2023年から2030年にかけてCAGR 8.8%で拡大し、2030年には1兆282億米ドルに達すると予測されています。

医療機器償還とは、医療機器の使用中に発生した費用に対して、第三者の民間または公的保険会社がヘルスケア提供者に支払う支払いと定義されます。業界の成長を促進する主な要因は、償還への依存度の高まり、慢性疾患の有病率の増加、予防医療の拡大です。早期診断と予防医療への注力は、診断機器業界における活動を活発化させ、その結果、より多くの償還シェアを促進する可能性があります。

例えば、乳がん検診の徹底など、診療報酬を通じて早期診断にインセンティブを与えるという基本的なパラダイムシフトが新興経済諸国全体で注目されています。COVID-19のパンデミックの間、ロボット支援手術などの手術は延期されました。しかし、パンデミックの回復期には、日本や中国のような国々が手術の精度を向上させるためにロボット支援プロバイダーへの償還提供に積極的に関与しているため、特にアジア太平洋地域ではこれらの手術が改善されると予想されます。このようなイニシアチブは、パンデミック後の市場成長に好影響を与える可能性が高いです。医療機器への需要が高まる中、償還サービスはヘルスケア業界に様々なビジネスチャンスをもたらすと予想されます。また、保険加入者の増加やヘルスケアシステムの統合は、業界の成長を後押しする大きな要因となっています。

北米は2022年の収益シェア50.2%以上で市場を独占しており、予測期間中もその優位性を維持すると予想されます。ヘルスケア機器に対する需要の高まりとヘルスケアセンターの増加が、この地域の業界を牽引すると見られています。慢性疾患の有病率の増加が、さまざまなヘルスケア機器の需要を促進しています。これはさらに、この地域市場の成長を支えるものと期待されています。例えば、2022年1月、Science Direct誌に掲載された研究によると、2011年から2021年の間に、画像診断検査に対する診療報酬は着実に減少しています。政府機関によるこの動向の継続は、パンデミック後の地域市場の成長にマイナスの影響を与えると予想されます。

医療機器償還市場のレポートハイライト

  • 多くの民間企業が参入しているため、2022年の売上シェアは65.0%超となり、民間支払機関が市場を独占しました。
  • ヘルスケア環境別では、最近の技術開発およびヘルスケア機器の使用を必要とする患者数の多さから、病院セグメントが2022年に51.8%超の最大売上シェアを占めました。
  • アジア太平洋地域は、農村部や都市部における保険サービスの普及率の上昇により、予測期間中に急成長を遂げると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療機器償還市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 医療機器償還市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 医療機器償還：支払者別推定・動向分析

  • 医療機器償還市場：重要なポイント
  • 医療機器償還市場：動向と市場シェア分析、2022年および2030年
  • 公共
  • 民間

第5章 医療機器償還：ヘルスケア環境別推定・動向分析

  • 医療機器償還市場：重要なポイント
  • 医療機器償還市場：動向と市場シェア分析、2022年および2030年
  • 病院
  • 外来施設
  • その他

第6章 医療機器償還市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別の医療機器償還市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • UnitedHealth Group
    • Cigna
    • Humana Inc.
    • Allianz
    • Aviva
    • CVS Health
    • WellCare Health Plans
    • Nippon Life Insurance Company
    • BNP Paribas
    • Anthem Insurance Companies, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 3 North America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 4 North America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 6 U.S. medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 7 Canada medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 8 Canada medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 9 Europe medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 10 Europe medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 11 Europe medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 13 Germany medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 14 UK medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 15 UK medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 16 France medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 17 France medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 18 Italy medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 19 Italy medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 20 Spain medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 21 Spain medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 22 Sweden medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 23 Sweden medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 24 Norway medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 25 Norway medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 26 Denmark medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 27 Denmark medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 31 China medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 32 China medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 33 Japan medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 34 Japan medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 35 India medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 36 India medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 37 Australia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 38 Australia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 39 Thailand medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 40 Thailand medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 41 South Korea medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 42 South Korea medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 43 Latin America medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 44 Latin America medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 45 Latin America medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 47 Brazil medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 48 Mexico medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 49 Mexico medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 50 Mexico medical device reimbursement market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 52 Argentina medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 55 Middle East and Africa medical device reimbursement market, by region, 2018 - 2030 (USD Million)
  • Table 56 South Africa medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 57 South Africa medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 60 UAE medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 61 UAE medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)
  • Table 62 Kuwait medical device reimbursement market, by payer, 2018 - 2030 (USD Million)
  • Table 63 Kuwait medical device reimbursement market, by healthcare setting, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Medical device reimbursement: Market outlook
  • Fig. 9 Medical device reimbursement: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Medical device reimbursement market driver impact
  • Fig. 15 Medical device reimbursement market restraint impact
  • Fig. 16 Medical device reimbursement market strategic initiatives analysis
  • Fig. 17 Medical device reimbursement market: Payer movement analysis
  • Fig. 18 Medical device reimbursement market: Payer outlook and key takeaways
  • Fig. 19 Public market estimates and forecasts, 2018 - 2030
  • Fig. 20 Private market estimates and forecasts, 2018 - 2030
  • Fig. 21 Medical device reimbursement market: Healthcare setting movement analysis
  • Fig. 22 Medical device reimbursement market: Healthcare setting outlook and key takeaways
  • Fig. 23 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 24 Outpatient facilities market estimates and forecasts, 2018 - 2030
  • Fig. 25 Other market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global medical device reimbursement market: Regional movement analysis
  • Fig. 27 Global medical device reimbursement market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-835-0

Medical Devices Reimbursement Market Growth & Trends:

The global medical devices reimbursement market size is expected to reach USD 1028.2 billion by 2030, expanding at a CAGR of 8.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Medical device reimbursement is defined as the payment a third-party private or public insurer pays a healthcare provider for the cost incurred while using medical equipment. The major factors fueling the industry growth are growing dependence on reimbursement, the increasing prevalence of chronic diseases, and growing preventive care. Focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more reimbursement share from them.

For instance, a fundamental paradigm shift towards incentivizing early diagnosis through reimbursement has been noticed across developed economies, such as thorough screening for breast cancer. During the COVID-19 pandemic, surgeries such as robotic-assisted procedures were postponed. However, during the pandemic recovery period, these surgeries are expected to improve particularly in Asia pacific as the countries such as Japan and China are actively involved in providing reimbursement to robotic-assisted providers to improve the accuracy of surgeries. Such initiatives are likely to have a positive impact on market growth in the post-pandemic period. With an increasing demand for medical equipment, reimbursement services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, the increasing number of people pursuing insurance and consolidation of the healthcare system are major factors fueling the industry growth.

North America dominated the market with a revenue share of over 50.2% in 2022 and is expected to maintain its dominance over the forecast period. The rising demand for healthcare equipment and the increasing number of healthcare centers are expected to drive the industry in this region. The growing prevalence of chronic diseases is driving the demand for various healthcare instruments. This is further expected to support the growth of the regional market. Over the years, the Centers for Medicare & Medicaid Services have reduced the reimbursement for diagnostic radiology in the U.S. For instance, in January 2022, a study published in Science Direct stated that, between 2011 - 2021, there was a steady decline in the reimbursement for diagnostic imaging studies. A continuation of this trend by the government agencies is expected to have a negative impact on the regional market growth in the post-pandemic period.

Medical Devices Reimbursement Market Report Highlights:

  • The private payer segment dominated the market with a revenue share of over 65.0% in 2022 due to the presence of a large number of private players
  • By healthcare setting, the hospitals segment held the largest revenue share of over 51.8% in 2022 due to recent technological developments and high patient footfall requiring the use of healthcare instruments
  • Asia Pacific is projected to witness rapid growth during the forecast period owing to the rising penetration of insurance services in rural and urban areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Payer
    • 1.1.2. Healthcare Setting
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Payer outlook
    • 2.2.2. Healthcare Setting outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Device Reimbursement Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Medical Device Reimbursement Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Medical Device Reimbursement: Payer Estimates & Trend Analysis

  • 4.1. Medical Device Reimbursement Market: Key Takeaways
  • 4.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Public
    • 4.3.1. Public market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Private
    • 4.4.1. Private market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Medical Device Reimbursement: Healthcare Setting Estimates & Trend Analysis

  • 5.1. Medical Device Reimbursement Market: Key Takeaways
  • 5.2. Medical Device Reimbursement Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Outpatient facilities
    • 5.4.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Medical Device Reimbursement Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Medical Device Reimbursement Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. UnitedHealth Group
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Cigna
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Humana Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Allianz
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Aviva
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. CVS Health
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. WellCare Health Plans
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Nippon Life Insurance Company
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. BNP Paribas
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Anthem Insurance Companies, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives